Google Alert - lose weight

	lose weight As-it-happens update ⋅ November 7, 2025
	NEWS
	U.S. deal could cut costs for popular weight-loss drugs. What's that mean for Canada? CBC A new deal with major drugmakers, unveiled by U.S. President Donald Trump on Thursday, aims to expand coverage and cut prices for popular ... Flag as irrelevant
	Trump announces deal to lower cost of weight loss drug - NBC News NBC News President Trump appeared in the oval office with executives from the companies behind GLP1 weight loss drug Wegovy and Zepbound to announce new ... Flag as irrelevant
	Trump announces deal to sell some weight loss drugs for as low as $150 on TrumpRX Fox Baltimore President Donald Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday that would allow some of their obesity drugs, like Wegovy and ... Flag as irrelevant
	Discover New Innovations at Invented at Duke 2025 Sites@Duke Express - Duke University ... lose weight quickly and safely. When taken by mouth, the sugar starts ... fat and muscle all over the body, this one only reduces visceral fat. Flag as irrelevant
	Ozempic Face Explained: Missouri Doctor Says It's Not Just About Looks - Missourinet Missourinet People even get skin infections and yeast infections in those folds." Wilson said anyone dealing with loose skin after rapid weight loss should bring ... Flag as irrelevant
	Trump unveils deals to lower costs of some weight-loss drugs | The Straits Times The Straits Times Both companies "have agreed to offer their most popular GLP-1 weight-loss drug," Mr Trump said at the White House, "at drastic discounts." "Eli Lilly ... Flag as irrelevant
	China Highlights Weight Management Products at 8th CIIE - Sixth Tone Sixth Tone ... lose weight — from gastric balloons and smartwatches to AI-driven fitness systems and health foods. The gadgets come amid China's three-year weight ... Flag as irrelevant
	President Trump Announces Weight Loss Drug Pricing Deal - YouTube YouTube President Trump: "Two world's largest pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, have agreed to offer their most popular GLP-1 ... Flag as irrelevant
	Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial - Medscape Medscape ATLANTA — Eli Lilly's investigational weekly amylin receptor agonist eloralintide produced significant weight loss over 48 weeks and was generally ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback